Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice

Journal of Immunology

Volumn 186, Issue 10, 2011, Pages 5916-5926

  Duggan, Jeffrey M ^a   You, Dahui ^a   Cleaver, Jeffrey O ^a   Larson, Derek T ^a   Garza, R Joshua ^a   Guzmán Pruneda, Francisco A ^b   Tuvim, Michael J ^a,c   Zhang, Jiexin ^a   Dickey, Burton F ^a,c   Evans, Scott E ^a,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LYSATE; LIGAND; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 9;

AEROSOL; ANIMAL EXPERIMENT; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL PNEUMONIA; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; INFECTION RESISTANCE; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; EPITHELIAL CELLS; FEMALE; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PNEUMONIA, BACTERIAL; PNEUMONIA, PNEUMOCOCCAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TOLL-LIKE RECEPTOR 9;

EID: 79953677281     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002122     Document Type: Article

References (64)

1. Mizgerd, J. P. 2006. Lung infection - a public health priority. PLoS Med. 3: e76.
2. Morens, D. M., G. K. Folkers, and A. S. Fauci. 2004. The challenge of emerging and re-emerging infectious diseases. Nature 430: 242-249.
3. WHO. 2004. The World Health Report 2004 - Changing History. World Health Organization, Geneva, Switzerland.
4. Rudan, I., L. Tomaskovic, C. Boschi-Pinto, H. Campbell; WHO Child Health Epidemiology Reference Group. 2004. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull. World Health Organ. 82: 895-903.
5. Holt, P. G., D. H. Strickland, M. E. Wikström, and F. L. Jahnsen. 2008. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 8: 142-152.
6. Martin, T. R., and C. W. Frevert. 2005. Innate immunity in the lungs. Proc. Am. Thorac. Soc. 2: 403-411.
7. Mizgerd, J. P. 2008. Acute lower respiratory tract infection. N. Engl. J. Med. 358: 716-727.
8. Bals, R., and P. S. Hiemstra. 2004. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur. Respir. J. 23: 327-333.
9. Bartlett, J. A., A. J. Fischer, and P. B. McCray, Jr. 2008. Innate immune functions of the airway epithelium. Contrib. Microbiol. 15: 147-163.
10. Hiemstra, P. S. 2007. The role of epithelial beta-defensins and cathelicidins in host defense of the lung. Exp. Lung Res. 33: 537-542.
11. Hippenstiel, S., B. Opitz, B. Schmeck, and N. Suttorp. 2006. Lung epithelium as a sentinel and effector system in pneumonia - molecular mechanisms of pathogen recognition and signal transduction. Respir. Res. 7: 97.
12. Schutte, B. C., and P. B. McCray, Jr. 2002. [beta]-defensins in lung host defense. Annu. Rev. Physiol. 64: 709-748.
13. Evans, S. E., Y. Xu, M. J. Tuvim, and B. F. Dickey. 2010. Inducible innate resistance of lung epithelium to infection. Annu. Rev. Physiol. 72: 413-435.
14. Brandl, K., G. Plitas, C. N. Mihu, C. Ubeda, T. Jia, M. Fleisher, B. Schnabl, R. P. DeMatteo, and E. G. Pamer. 2008. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455: 804-807.
15. Clement, C. G., S. E. Evans, C. M. Evans, D. Hawke, R. Kobayashi, P. R. Reynolds, S. J. Moghaddam, B. L. Scott, E. Melicoff, R. Adachi, et al. 2008. Stimulation of lung innate immunity protects against lethal pneumococcal pneumonia in mice. Am. J. Respir. Crit. Care Med. 177: 1322-1330.
16. Clement, C. G., M. J. Tuvim, C. M. Evans, D. M. Tuvin, B. F. Dickey, and S. E. Evans. 2009. Allergic lung inflammation alters neither susceptibility to Streptococcus pneumoniae infection nor inducibility of innate resistance in mice. Respir. Res. 10: 70.
17. Evans, S. E., B. L. Scott, C. G. Clement, D. T. Larson, D. Kontoyiannis, R. E. Lewis, P. R. Lasala, J. Pawlik, J. W. Peterson, A. K. Chopra, et al. 2010. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am. J. Respir. Cell Mol. Biol. 42: 40-50.
18. Tuvim, M. J., S. E. Evans, C. G. Clement, B. F. Dickey, and B. E. Gilbert. 2009. Augmented lung inflammation protects against influenza A pneumonia. PLoS ONE 4: e4176.
19. Ishii, K. J., S. Koyama, A. Nakagawa, C. Coban, and S. Akira. 2008. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe 3: 352-363. (Pubitemid 351773099)
20. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
21. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801. (Pubitemid 43261452)
22. Shi, Z., Z. Cai, S. Wen, C. Chen, C. Gendron, A. Sanchez, K. Patterson, S. Fu, J. Yang, D. Wildman, et al. 2009. Transcriptional regulation of the novel Toll-like receptor Tlr13. J. Biol. Chem. 284: 20540-20547.
23. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho, H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Takeda, and S. Akira. 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643. (Pubitemid 36927946)
24. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
25. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
26. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150. (Pubitemid 28361303)
27. Moghaddam, S. J., C. G. Clement, M. M. De la Garza, X. Zou, E. L. Travis, H. W. Young, C. M. Evans, M. J. Tuvim, and B. F. Dickey. 2008. Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am. J. Respir. Cell Mol. Biol. 38: 629-638.
28. You, Y., E. J. Richer, T. Huang, and S. L. Brody. 2002. Growth and differentiation of mouse tracheal epithelial cells: selection of a proliferative population. Am. J. Physiol. Lung Cell. Mol. Physiol. 283: L1315-L1321.
29. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2: 253-258.
30. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739.
31. Buwitt-Beckmann, U., H. Heine, K. H. Wiesmüller, G. Jung, R. Brock, and A. J. Ulmer. 2005. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J. 272: 6354-6364.
32. Hayashi, F., K. D. Smith, A. Ozinsky, T. R. Hawn, E. C. Yi, D. R. Goodlett, J. K. Eng, S. Akira, D. M. Underhill, and A. Aderem. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410: 1099-1103. (Pubitemid 32391041)
33. Krug, A., S. Rothenfusser, V. Hornung, B. Jahrsdörfer, S. Blackwell, Z. K. Ballas, S. Endres, A. M. Krieg, and G. Hartmann. 2001. Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31: 2154-2163.
34. Lee, J., T. H. Chuang, V. Redecke, L. She, P. M. Pitha, D. A. Carson, E. Raz, and H. B. Cottam. 2003. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 100: 6646-6651.
35. Martin, M., S. M. Michalek, and J. Katz. 2003. Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A. Infect. Immun. 71: 2498-2507.
36. Evans, C. M., O. W. Williams, M. J. Tuvim, R. Nigam, G. P. Mixides, M. R. Blackburn, F. J. DeMayo, A. R. Burns, C. Smith, S. D. Reynolds, et al. 2004. Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. Am. J. Respir. Cell Mol. Biol. 31: 382-394.
37. Beutler, B. A. 2009. TLRs and innate immunity. Blood 113: 1399-1407.
38. Dostert, C., E. Meylan, and J. Tschopp. 2008. Intracellular pattern-recognition receptors. Adv. Drug Deliv. Rev. 60: 830-840.
39. Kagan, J. C., T. Su, T. Horng, A. Chow, S. Akira, and R. Medzhitov. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9: 361-368.
40. Cluff, C. W., J. R. Baldridge, A. G. Stöver, J. T. Evans, D. A. Johnson, M. J. Lacy, V. G. Clawson, V. M. Yorgensen, C. L. Johnson, M. T. Livesay, et al. 2005. Synthetic toll-like receptor 4 agonists stimulate innate resistance to infectious challenge. Infect. Immun. 73: 3044-3052.
41. Lee, J. S., C. W. Frevert, G. Matute-Bello, M. M. Wurfel, V. A. Wong, S. M. Lin, J. Ruzinski, S. Mongovin, R. B. Goodman, and T. R. Martin. 2005. TLR-4 pathway mediates the inflammatory response but not bacterial elimination in E. coli pneumonia. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L731-L738.
42. Medzhitov, R. 2007. Recognition of microorganisms and activation of the immune response. Nature 449: 819-826. (Pubitemid 47598622)
43. Yu, F. S., M. D. Cornicelli, M. A. Kovach, M. W. Newstead, X. Zeng, A. Kumar, N. Gao, S. G. Yoon, R. L. Gallo, and T. J. Standiford. 2010. Flagellin stimulates protective lung mucosal immunity: role of cathelicidin-related antimicrobial peptide. J. Immunol. 185: 1142-1149.
44. Deng, J. C., T. A. Moore, M. W. Newstead, X. Zeng, A. M. Krieg, and T. J. Standiford. 2004. CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J. Immunol. 173: 5148-5155.
45. Reppe, K., T. Tschernig, A. Lührmann, V. van Laak, K. Grote, M. V. Zemlin, B. Gutbier, H. C. Müller, M. Kursar, H. Schü tte, et al. 2009. Immunostimulation with macrophage-activating lipopeptide-2 increased survival in murine pneumonia. Am. J. Respir. Cell. Mol. Biol. 40: 474-481.
46. Standiford, T. J., and J. C. Deng. 2004. Immunomodulation for the prevention and treatment of lung infections. Semin. Respir. Crit. Care Med. 25: 95-108.
47. Kanzler, H., F. J. Barrat, E. M. Hessel, and R. L. Coffman. 2007. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat. Med. 13: 552-559.
48. Ulevitch, R. J. 2004. Therapeutics targeting the innate immune system. Nat. Rev. Immunol. 4: 512-520.
49. Bafica, A., H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher. 2006. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J. Immunol. 177: 3515-3519. (Pubitemid 44359881)
50. Bafica, A., C. A. Scanga, C. G. Feng, C. Leifer, A. Cheever, and A. Sher. 2005. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J. Exp. Med. 202: 1715-1724.
51. Sato, A., M. M. Linehan, and A. Iwasaki. 2006. Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. USA 103: 17343-17348.
52. Sørensen, L. N., L. S. Reinert, L. Malmgaard, C. Bartholdy, A. R. Thomsen, and S. R. Paludan. 2008. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J. Immunol. 181: 8604-8612.
53. Chang, Y. J., M. S. Wu, J. T. Lin, and C. C. Chen. 2005. Helicobacter pylori-Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation. J. Immunol. 175: 8242-8252.
54. Chang, Y. J., M. S. Wu, J. T. Lin, B. S. Sheu, T. Muta, H. Inoue, and C. C. Chen. 2004. Induction of cyclooxygenase-2 overexpression in human gastric epithelial cells by Helicobacter pylori involves TLR2/TLR9 and c-Src-dependent nuclear factor-kappaB activation. Mol. Pharmacol. 66: 1465-1477.
55. Lee, K. S., C. A. Scanga, E. M. Bachelder, Q. Chen, and C. M. Snapper. 2007. TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. Cell. Immunol. 245: 103-110.
56. Lai, Y., and R. L. Gallo. 2009. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30: 131-141.
57. Singh, P. K., B. F. Tack, P. B. McCray, Jr., and M. J. Welsh. 2000. Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am. J. Physiol. Lung Cell. Mol. Physiol. 279: L799-L805.
58. Jurk, M., A. Kritzler, H. Debelak, J. Vollmer, A. M. Krieg, and E. Uhlmann. 2006. Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists. ChemMedChem 1: 1007-1014. (Pubitemid 44448800)
59. Vollmer, J., M. Jurk, U. Samulowitz, G. Lipford, A. Forsbach, M. Wüllner, S. Tluk, H. Hartmann, A. Kritzler, C. Müller, et al. 2004. CpG oligodeoxynucleotides stimulate IFN-gamma-inducible protein-10 production in human B cells. J. Endotoxin Res. 10: 431-438. (Pubitemid 39618559)
60. Vollmer, J., and A. M. Krieg. 2009. Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists. Adv. Drug Deliv. Rev. 61: 195-204.
61. Vollmer, J., R. Weeratna, P. Payette, M. Jurk, C. Schetter, M. Laucht, T. Wader, S. Tluk, M. Liu, H. L. Davis, and A. M. Krieg. 2004. Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34: 251-262.
62. Krieg, A. M. 2006. Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5: 471-484.
63. Dietrich, N., S. Lienenklaus, S. Weiss, and N. O. Gekara. 2010. Murine toll-like receptor 2 activation induces type I interferon responses from endolysosomal compartments. PLoS ONE 5: e10250.
64. Sasai, M., M. M. Linehan, and A. Iwasaki. 2010. Bifurcation of Toll-like receptor 9 signaling by adaptor protein 3. Science 329: 1530-1534.